Literature DB >> 31471117

Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study.

Filomena Caria1, Matilde Cescon2, Francesca Gualandi3, Anna Pichiecchio4, Rachele Rossi3, Paola Rimessi3, Stefano Cotti Piccinelli1, Serena Gallo Cassarino1, Ilaria Gregorio2, Anna Galvagni1, Alessandra Ferlini3, Alessandro Padovani1, Paolo Bonaldo2, Massimiliano Filosto5.   

Abstract

Bethlem myopathy represents the milder form of the spectrum of Collagen VI-related dystrophies, which are characterized by a clinical continuum between the two extremities, the Bethlem myopathy and the Ullrich congenital muscular dystrophy, and include less defined intermediate phenotypes. Bethlem myopathy is mainly an autosomal dominant disorder and the causing mutations occur in the COL6A genes encoding for the α1 (COL6A1), α2 (COL6A2) and α3 (COL6A3) chains. However, few cases of recessive inheritance have been also reported. We here describe clinical, genetic and functional findings in a recessive Bethlem myopathy family harbouring two novel pathogenic mutations in the COL6A2 gene. Two adult siblings presented with muscle weakness and wasting, elbows and Achilles tendon retractions, lumbar hyperlordosis, waddling gait and positive Gowers' sign. Muscle biopsy showed a dystrophic pattern. Molecular analysis of the COL6A2 gene revealed the novel paternally-inherited nonsense p.Gln889* mutation and the maternally-inherited p.Pro260_Lys261insProPro small insertion. Fibroblast studies in both affected patients showed the concomitant reduction in the amount of normal Collagen VI (p.Gln889*) and impairment of Collagen VI secretion and assembly (p.Pro260_Lys261insProPro). Each of the two variants behave as a recessive mutation as shown by the asymptomatic heterozygous parents, while their concomitant effects determined a relatively mild Bethlem myopathy phenotype. This study confirms the occurrence of recessive inherited Bethlem myopathy and expands the genetic heterogeneity of this group of muscle diseases.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bethlem myopathy; COL6A2; Collagen VI; Ullrich congenital muscular dystrophy

Year:  2019        PMID: 31471117     DOI: 10.1016/j.nmd.2019.07.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

1.  Intrafamilial Phenotypic Variability of Collagen VI-Related Myopathy Due to a New Mutation in the COL6A1 Gene.

Authors:  Sergey N Bardakov; Roman V Deev; Raisat M Magomedova; Zoya R Umakhanova; Valérie Allamand; Corine Gartioux; Kamil Z Zulfugarov; Patimat G Akhmedova; Vadim A Tsargush; Angelina A Titova; Mikhail O Mavlikeev; Vadim L Zorin; Ekaterina N Chernets; Gimat D Dalgatov; Fedor A Konovalov; Artur A Isaev
Journal:  J Neuromuscul Dis       Date:  2021

2.  Genotype-Phenotype Correlation of the Childhood-Onset Bethlem Myopathy in the Mediterranean Region of Turkey.

Authors:  Muhammet G Kutluk; Naz Kadem; Omer Bektas; Nadide C Randa; Gökcen O Tuncer; Pelin Albayrak; Tuba Eminoglu; Serap T Teber
Journal:  Ann Indian Acad Neurol       Date:  2021-04-05       Impact factor: 1.383

Review 3.  Into the Tissues: Extracellular Matrix and Its Artificial Substitutes: Cell Signalling Mechanisms.

Authors:  Aleksandra Bandzerewicz; Agnieszka Gadomska-Gajadhur
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

4.  A Novel Variant of COL6A2 Gene Causing Bethlem Myopathy and Evaluation of Essential Hypertension.

Authors:  M Gultekin Kutluk; Naz Kadem; Omer Bektas; Nadide Cemre Randa; Gökcen Oz Tuncer; Pelin Albayrak; Tuba Eminoglu; Serap Tiras Teber
Journal:  Ann Indian Acad Neurol       Date:  2020-09-02       Impact factor: 1.383

5.  Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.

Authors:  Jiali Li; Zihang Zeng; Xueping Jiang; Nannan Zhang; Yanping Gao; Yuan Luo; Wenjie Sun; Shuying Li; Jiangbo Ren; Yan Gong; Conghua Xie
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.